FDA approves drug for rare form of ALS

by Cara MurezThe U.S. Food and Drug Administration on Tuesdayapproveda new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig&

Updated on: March 30,2024 12

FDA approves drug for rare form of ALS

by Cara MurezThe U.S. Food and Drug Administration on Tuesdayapproveda new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig&

Updated on:March 30,2024 12

Maria shriver and AARP take on Alzheimer's in women

by Serena Gordon, Healthday ReporterMaria Shriver(HealthDay)—An Alzheimer's diagnosis is devastating, no matter your sex. But the disease strikes far more women than men.Journalist and author Mari

Updated on: March 30,2024 15

Maria shriver and AARP take on Alzheimer's in women

by Serena Gordon, Healthday ReporterMaria Shriver(HealthDay)—An Alzheimer's diagnosis is devastating, no matter your sex. But the disease strikes far more women than men.Journalist and author Mari

Updated on:March 30,2024 15

Caregiver burden in dementia during the COVID-19 crisis

by IOS PressCredit: CC0 Public DomainCaregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms a

Updated on: March 30,2024 16

Caregiver burden in dementia during the COVID-19 crisis

by IOS PressCredit: CC0 Public DomainCaregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms a

Updated on:March 30,2024 16

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024 16

FDA panel urges rejection of experimental Alzheimer's drug

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024 16

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024 13

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024 13

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024 18

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024 18

Overlapping mechanisms in HIV cognitive disorders and Alzheimer's disease

by Society for NeuroscienceAβ oligomers are elevated in the brains of HIV(+) cases. Paraffin-embedded tissue sections from hippocampus of HIV(-) and HIV(+) individuals were prepared for immunoflu

Updated on: March 30,2024 18

Overlapping mechanisms in HIV cognitive disorders and Alzheimer's disease

by Society for NeuroscienceAβ oligomers are elevated in the brains of HIV(+) cases. Paraffin-embedded tissue sections from hippocampus of HIV(-) and HIV(+) individuals were prepared for immunoflu

Updated on:March 30,2024 18

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on: March 30,2024 20

GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

by Emory UniversityGluN3A (in the diagram, NR3) is an inhibitory subunit within NMDA receptor assemblies, which function as glutamate-gated cation channels. GluN3A is a key regulator of neuronal

Updated on:March 30,2024 20

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on: March 30,2024 16

HBOT showed improvement in Alzheimer's disease

by Louisiana State UniversityCredit: Louisiana State UniversityDr. Paul Harch, Clinical Professor and Director of Hyperbaric Medicine at LSU Health New Orleans School of Medicine, and Dr. Edward

Updated on:March 30,2024 16

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024 14

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024 14

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on: March 30,2024 11

Lecanemab: Experimental drug is a ray of hope for Alzheimer's disease

by Frederic Calon and Étienne Aumont,The ConversationCredit: AI-generated imageOn Nov. 30, Eisai and Biogen announced theresults of their latest phase 3 clinical trial in Alzheimer's d

Updated on:March 30,2024 11

Dementia more common in adults with HIV

(HealthDay)—People older than 50 years with HIV are more likely to have dementia than people without HIV, according to a study published online Nov. 24 inAIDS.Jennifer O. Lam, from Kaiser Perman

Updated on: March 30,2024 13

Dementia more common in adults with HIV

(HealthDay)—People older than 50 years with HIV are more likely to have dementia than people without HIV, according to a study published online Nov. 24 inAIDS.Jennifer O. Lam, from Kaiser Perman

Updated on:March 30,2024 13